-
Most Popular
Earnings Reports
QFIN Stock Earnings: Qifu Technology Reported Results for Q2 2024
Qifu Technology just reported results for the second quarter of 2024.
WILC Stock Earnings: G. Willi-Food Intl Reported Results for Q2 2024
G. Willi-Food Intl just reported results for the second quarter of 2024.
IDAI Stock Earnings: T Stamp Beats EPS, Misses Revenue for Q2 2024
IDAI stock results show that T Stamp beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
QNCX Stock Earnings: Quince Therapeutics Reported Results for Q2 2024
Quince Therapeutics just reported results for the second quarter of 2024.
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q2 2024
Hepion Pharmaceuticals just reported results for the second quarter of 2024.
GXAI Stock Earnings: Gaxos.AI Reported Results for Q2 2024
Gaxos.AI just reported results for the second quarter of 2024.
IPDN Stock Earnings: Professional Diversity Reported Results for Q2 2024
Professional Diversity just reported results for the second quarter of 2024.
SLDB Stock Earnings: Solid Biosciences Beats EPS for Q2 2024
SLDB stock results show that Solid Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
SNAL Stock Earnings: Snail Misses EPS, Misses Revenue for Q2 2024
SNAL stock results show that Snail missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
ICU Stock Earnings: SeaStar Medical Holding Beats EPS for Q2 2024
ICU stock results show that SeaStar Medical Holding beat analyst estimates for earnings per share the second quarter of 2024.
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024
CDTX stock results show that Cidara Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024
NKTX stock results show that Nkarta beat analyst estimates for earnings per share the second quarter of 2024.
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2024
ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2024.
KRRO Stock Earnings: Korro Bio Misses EPS for Q2 2024
KRRO stock results show that Korro Bio missed analyst estimates for earnings per share the second quarter of 2024.
WKSP Stock Earnings: Worksport Misses EPS, Beats Revenue for Q2 2024
WKSP stock results show that Worksport missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
XCUR Stock Earnings: Exicure Reported Results for Q2 2024
Exicure just reported results for the second quarter of 2024.
ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024
ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
CTNM Stock Earnings: Contineum Therapeutics Misses EPS for Q2 2024
CTNM stock results show that Contineum Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
